Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2012 1
2013 2
2014 3
2015 3
2016 4
2017 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
Towards tailored radiopeptide therapy.
Radojewski P, Dumont R, Marincek N, Brunner P, Mäcke HR, Müller-Brand J, Briel M, Walter MA. Radojewski P, et al. Among authors: marincek n. Eur J Nucl Med Mol Imaging. 2015 Jul;42(8):1231-7. doi: 10.1007/s00259-015-3030-9. Epub 2015 Mar 20. Eur J Nucl Med Mol Imaging. 2015. PMID: 25792454 Free article.
Indium-111 labeled gold nanoparticles for in-vivo molecular targeting.
Ng QK, Olariu CI, Yaffee M, Taelman VF, Marincek N, Krause T, Meier L, Walter MA. Ng QK, et al. Among authors: marincek n. Biomaterials. 2014 Aug;35(25):7050-7. doi: 10.1016/j.biomaterials.2014.04.098. Epub 2014 May 17. Biomaterials. 2014. PMID: 24840614
Upregulation of Key Molecules for Targeted Imaging and Therapy.
Taelman VF, Radojewski P, Marincek N, Ben-Shlomo A, Grotzky A, Olariu CI, Perren A, Stettler C, Krause T, Meier LP, Cescato R, Walter MA. Taelman VF, et al. Among authors: marincek n. J Nucl Med. 2016 Nov;57(11):1805-1810. doi: 10.2967/jnumed.115.165092. Epub 2016 Jun 30. J Nucl Med. 2016. PMID: 27363833 Free article.
The prognostic and predictive value of sstr2-immunohistochemistry and sstr2-targeted imaging in neuroendocrine tumors.
Brunner P, Jörg AC, Glatz K, Bubendorf L, Radojewski P, Umlauft M, Marincek N, Spanjol PM, Krause T, Dumont RA, Maecke HR, Müller-Brand J, Briel M, Schmitt A, Perren A, Walter MA. Brunner P, et al. Among authors: marincek n. Eur J Nucl Med Mol Imaging. 2017 Mar;44(3):468-475. doi: 10.1007/s00259-016-3486-2. Epub 2016 Aug 18. Eur J Nucl Med Mol Imaging. 2017. PMID: 27539020 Free article. Clinical Trial.
Somatostatin-based radiopeptide therapy with [177Lu-DOTA]-TOC versus [90Y-DOTA]-TOC in neuroendocrine tumours.
Romer A, Seiler D, Marincek N, Brunner P, Koller MT, Ng QK, Maecke HR, Müller-Brand J, Rochlitz C, Briel M, Schindler C, Walter MA. Romer A, et al. Among authors: marincek n. Eur J Nucl Med Mol Imaging. 2014 Feb;41(2):214-22. doi: 10.1007/s00259-013-2559-8. Epub 2013 Oct 2. Eur J Nucl Med Mol Imaging. 2014. PMID: 24085501 Free article. Clinical Trial.
Reply: Diabetes Mellitus and Its Effects on All-Cause Mortality After Radiopeptide Therapy for Neuroendocrine Tumors: Methodologic Issues.
Umlauft M, Radojewski P, Spanjol PM, Dumont R, Marincek N, Kollar A, Brunner P, Beyersmann J, Müller-Brand J, Maecke HR, Laimer M, Walter MA. Umlauft M, et al. Among authors: marincek n. J Nucl Med. 2017 Sep;58(9):1532. doi: 10.2967/jnumed.117.190660. Epub 2017 Mar 9. J Nucl Med. 2017. PMID: 28280219 Free article. No abstract available.
13 results